Head-To-Head Contrast: Clarivate (NYSE:CLVT) vs. Fobi AI (OTCMKTS:FOBIF)

Fobi AI (OTCMKTS:FOBIFGet Free Report) and Clarivate (NYSE:CLVTGet Free Report) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, profitability, earnings, analyst recommendations, institutional ownership, dividends and valuation.

Risk & Volatility

Fobi AI has a beta of -0.02, suggesting that its share price is 102% less volatile than the S&P 500. Comparatively, Clarivate has a beta of 1.38, suggesting that its share price is 38% more volatile than the S&P 500.

Earnings and Valuation

This table compares Fobi AI and Clarivate”s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Fobi AI $370,000.00 101.96 -$800,000.00 ($0.02) -7.50
Clarivate $2.46 billion 0.51 -$201.10 million ($0.21) -9.26

Fobi AI has higher earnings, but lower revenue than Clarivate. Clarivate is trading at a lower price-to-earnings ratio than Fobi AI, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Fobi AI and Clarivate’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Fobi AI N/A N/A N/A
Clarivate -5.61% 8.82% 3.86%

Analyst Recommendations

This is a summary of current recommendations and price targets for Fobi AI and Clarivate, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fobi AI 0 0 0 0 0.00
Clarivate 3 4 0 0 1.57

Clarivate has a consensus price target of $2.98, indicating a potential upside of 53.21%. Given Clarivate’s stronger consensus rating and higher probable upside, analysts clearly believe Clarivate is more favorable than Fobi AI.

Institutional & Insider Ownership

85.7% of Clarivate shares are held by institutional investors. 22.9% of Clarivate shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Clarivate beats Fobi AI on 8 of the 13 factors compared between the two stocks.

About Fobi AI

(Get Free Report)

Fobi AI Inc., together with its subsidiaries, operates as a technology and data intelligence company in North America and Europe. It provides software as a service; consulting and development services; and resells, refers, and licenses its products. The company also offers mobile wallet solutions, digital coupons, and customer insights solutions. It serves various industries, including the hospitality and tourism industries. The company was formerly known as Loop Insights Inc. Fobi AI Inc. is based in Vancouver, Canada.

About Clarivate

(Get Free Report)

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications. It also provides Patent and Trademark Renewals, that supports paralegal and admin tasks throughout the patent and trademark protection and maintenance process; CompuMark and Derwent, that supports critical decisions around patent and trademark protection, risk, and value creation throughout the innovation and brand lifecycle; IPFolio and Foundation IP that creates a structured environment for the protection and management of global patent and trademark assets. In addition, the company offers Cortellis Competitive Intelligence and Cortellis Drug Discovery Intelligence, that supports the development of new drugs and medical devices from discovery to clinical trials; Cortellis Regulatory Intelligence and OFF-X to monitor drug safety issues and adhere to regulatory protocols; Real World Data and Optimize that inform commercial launch strategy and set pricing for optimal reimbursement. It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.

Receive News & Ratings for Fobi AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fobi AI and related companies with MarketBeat.com's FREE daily email newsletter.